Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier

Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier

Source: 
Endpoints
snippet: 

Michael Varney began his post-Genentech career by taking a job as chairman of R&D at a biotech startup. Now he’s signed on for a new gig that will put him in direct contact with a whole lot more.